AliveCor’s Smartphone-Linked ECG First Product Assessed Under UK’s Rapid HTA Pilot

NICE’s recently launched early value assessment (EVA) pilot has hit a milestone this month, with AliveCor’s KardiaMobile 6L the first product to be given the go-ahead for NHS use in England under the scheme.

KardiaMobile 6L EKG device with an iPhone X
• Source: AliveCor

The KardiaMobile 6L, a portable ECG that wirelessly records and transmits data, is the first to have received a draft recommendation by the UK National Institute for Health and Care Excellence (NICE) following a rapid assessment from its diagnostics advisory committee. The resulting guidance, once finalized, will see the device offered to certain NHS patients within psychiatric settings on a conditional basis while further data are collected for a full assessment.

The device, which is already used within the NHS for the ambulatory detection of atrial fibrillation, can detect heart problems such as rhythm disturbances which in turn can inform the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cardiology

More from Device Area